Invitae appoints Robert Guigley as Chief Commercial Officer

Invitae has appointed Robert Guigley as its Chief Commercial Officer, effective September 5. Guigley most recently served as chief commercial officer at Ambry Genetics. Guigley began his career in pharmaceutical sales at AstraZeneca, giving him a strong foundation in selling to physicians. He then migrated into diagnostics, leading sales and market access at Quest Diagnostics and Counsyl. Pursuant to his hiring as the company’s chief commercial officer, Invitae is granting 850K restricted stock units to Rob Guigley under Invitae’s 2015 Stock Incentive Plan, which will be amended and restated to add 850K shares of Invitae common stock to a pool of shares under the 2015 Plan which is to be used exclusively for the grant of inducement awards.